Multiplexed Diagnostics Market: By Product, By Application, By Technology, By End User, and Geography 

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Multiplexed Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Reagents and Consumables, Analyzers), By Application (Disease Diagnostics, Molecular Diagnostics, and Drug Development), By Technology (Very High Density Multiplexed Assays, High Density Multiplexed Assays, Medium Density Multiplexed Assays, Low-Density Multiplexed Assays, and Next Generation Sequencing Assays), By End User (Hospitals, Diagnostic Centers, and Research Centers), and Region 

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Multiplexed Diagnostics Market size was valued at US$ 8,921.4 million in 2023, and growing at a CAGR of 16.2% from 2024 to 2030. The global market provides a detailed overview that can be segmented by product, by application, and by end user. By product, the global multiplexed diagnostics market has been segmented into Reagents Consumables and Analyzers. The Reagents and Consumables segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. Based on application, the global multiplexed diagnostics market is segmented into Disease Diagnostics, Molecular Diagnostics, and Drug Development), By Technology (Very High-Density Multiplexed Assays, High Density Multiplexed Assays, Medium Density Multiplexed Assays, Low Density Multiplexed Assays, and Next Generation Sequencing Assays.

Among these, the Molecular Diagnostics segment is expected to have the fastest-growing market during the forecast period. Based on end user, the global multiplexed diagnostics market is segmented into Hospitals, Diagnostic Centers, and Research Centers. Hosted segment is the second-largest share during the forecast period. Multiplexed Diagnostics are utilized as a part of examination of biological samples, which are fit for finishing a screening procedure with a solitary run. Multiplexed assay tests are engaged with the discovery and analysis of various illnesses and contaminations, which incorporate growths, immune system ailments, hypersensitivities, and cardiovascular infections.

Multiplexed Diagnostics Market Key Development:

  • In Oct 2022, Genes2Me launched Rapi-Q- Point of Care RT PCR for diseases like HPV and Tuberculosis.
  • In Oct 2022, Multi-omics Startup Pleno Inc. announced $40 Million in series a funding led by deerfield management with participation by foresite capital.

summary download arrow Download Free Sample

Global Multiplexed Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

16.2%

Largest Market

North America

Fastest Growing Market

Asia pacific

Multiplexed Diagnostics Market Dynamics

Growing incidence of various types of cancers and infectious diseases are anticipated to propel the market growth over the forecast years.

Global Multiplexed Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 8,921.4 million

Market CAGR

16.2%

By product

  • Reagents and Consumables
  • Analyzers

By Technology

  • Very High Density Multiplexed Assays
  • High Density Multiplexed Assays
  • Medium Density Multiplexed Assays
  • Low Density Multiplexed Assays
  • Next Generation Sequencing Assays

By Application

  • Disease Diagnostics
  • Molecular Diagnostics
  • Drug Development

By End User

  • Hospitals
  • Diagnostic Centres
  • Research Centres

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The multiplexed diagnostics market size was valued at US$ 8,921.4 million in 2023

The multiplexed diagnostics market key players are: Thermo Fisher Scientific, Inc. (U.S.) QIAGEN N.V. (Netherlands) Luminex Corporation (U.S.) Bio-Rad Laboratories(U.S.) Illumina, Inc. (U.S.), Inc.

The multiplexed diagnostics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

 

1. Executive Summary
2. Global Multiplexed Diagnostics Market Introduction 
2.1.Global Multiplexed Diagnostics Market  - Taxonomy
2.2.Global Multiplexed Diagnostics Market  - Definitions
2.2.1.product
2.2.2.Technology
2.2.3.Application
2.2.4.End User
2.2.5.Region
3. Global Multiplexed Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Multiplexed Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 -2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Multiplexed Diagnostics Market by Product, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
5.1. Reagents and Consumables
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Analyzers
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Multiplexed Diagnostics Market  By Technology, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
6.1. Very High-Density Multiplexed Assays
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. High Density Multiplexed Assays
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Medium Density Multiplexed Assays
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Low-Density Multiplexed Assays
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Next Generation Sequencing Assays
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Multiplexed Diagnostics Market  By Application, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
7.1. Disease Diagnostics
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Molecular Diagnostics
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Drug Development
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Multiplexed Diagnostics Market  By End User, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Diagnostic Centres
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Research Centres
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9. Global Multiplexed Diagnostics Market  By Region, 2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 -2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Multiplexed Diagnostics Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
10.1. product Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Reagents and Consumables
10.1.2.Analyzers
10.2.  Technology Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Very High Density Multiplexed Assays
10.2.2.High Density Multiplexed Assays
10.2.3.Medium Density Multiplexed Assays
10.2.4.Low Density Multiplexed Assays
10.2.5.Next Generation Sequencing Assays
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Disease Diagnostics
10.3.2.Molecular Diagnostics
10.3.3.Drug Development
10.4.  End User Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Diagnostic Centres
10.4.3.Research Centres
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Multiplexed Diagnostics Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
11.1. product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Reagents and Consumables
11.1.2.Analyzers
11.2.  Technology Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Very High Density Multiplexed Assays
11.2.2.High Density Multiplexed Assays
11.2.3.Medium Density Multiplexed Assays
11.2.4.Low Density Multiplexed Assays
11.2.5.Next Generation Sequencing Assays
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Disease Diagnostics
11.3.2.Molecular Diagnostics
11.3.3.Drug Development
11.4.  End User Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Diagnostic Centres
11.4.3.Research Centres
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Multiplexed Diagnostics Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
12.1. product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Reagents and Consumables
12.1.2.Analyzers
12.2.  Technology Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Very High Density Multiplexed Assays
12.2.2.High Density Multiplexed Assays
12.2.3.Medium Density Multiplexed Assays
12.2.4.Low Density Multiplexed Assays
12.2.5.Next Generation Sequencing Assays
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Disease Diagnostics
12.3.2.Molecular Diagnostics
12.3.3.Drug Development
12.4.  End User Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Diagnostic Centres
12.4.3.Research Centres
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Multiplexed Diagnostics Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
13.1. product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Reagents and Consumables
13.1.2.Analyzers
13.2.  Technology Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Very High Density Multiplexed Assays
13.2.2.High Density Multiplexed Assays
13.2.3.Medium Density Multiplexed Assays
13.2.4.Low Density Multiplexed Assays
13.2.5.Next Generation Sequencing Assays
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Disease Diagnostics
13.3.2.Molecular Diagnostics
13.3.3.Drug Development
13.4.  End User Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Diagnostic Centres
13.4.3.Research Centres
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Multiplexed Diagnostics Market ,2019 - 2023 and Forecast 2024 -2030 (Sales Value USD Million)
14.1. product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Reagents and Consumables
14.1.2.Analyzers
14.2.  Technology Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Very High Density Multiplexed Assays
14.2.2.High Density Multiplexed Assays
14.2.3.Medium Density Multiplexed Assays
14.2.4.Low Density Multiplexed Assays
14.2.5.Next Generation Sequencing Assays
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Disease Diagnostics
14.3.2.Molecular Diagnostics
14.3.3.Drug Development
14.4.  End User Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Diagnostic Centres
14.4.3.Research Centres
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Thermo Fisher Scientific, Inc. (U.S.)
15.2.2.QIAGEN N.V. (Netherlands)
15.2.3.Luminex Corporation (U.S.)
15.2.4.Bio-Rad Laboratories(U.S.)
15.2.5.Illumina, Inc. (U.S.), Inc.
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Thermo Fisher Scientific, Inc. (U.S.)
  • QIAGEN N.V. (Netherlands)
  • Luminex Corporation (U.S.)
  • Bio-Rad Laboratories(U.S.)
  • Illumina, Inc. (U.S.), Inc.

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market